Machine Learning Approaches to Evaluate Heterogeneous Treatment Effects in Randomized Controlled Trials: A Scoping Review.

Heterogeneous treatment effect Individualized treatment effect Machine learning Randomized controlled trial personalized medicine

Journal

Journal of clinical epidemiology
ISSN: 1878-5921
Titre abrégé: J Clin Epidemiol
Pays: United States
ID NLM: 8801383

Informations de publication

Date de publication:
19 Sep 2024
Historique:
received: 15 05 2024
revised: 06 09 2024
accepted: 16 09 2024
medline: 22 9 2024
pubmed: 22 9 2024
entrez: 21 9 2024
Statut: aheadofprint

Résumé

Estimating heterogeneous treatment effects (HTEs) in randomized controlled trials (RCTs) has received substantial attention recently. This has led to the development of several statistical and machine learning (ML) algorithms to assess HTEs through identifying individualized treatment effects. However, a comprehensive review of these algorithms is lacking. We thus aimed to catalog and outline currently available statistical and ML methods for identifying HTEs via effect modeling using clinical RCT data and summarize how they have been applied in practice. We performed a scoping review using pre-specified search terms in MEDLINE and Embase, aiming to identify studies that assessed HTEs using advanced statistical and ML methods in RCT data published from 2010 to 2022. Among a total of 32 studies identified in the review, 17 studies applied existing algorithms to RCT data, and 15 extended existing algorithms or proposed new algorithms. Applied algorithms included penalized regression, causal forest, Bayesian causal forest, and other meta-learner frameworks. Of these methods, causal forest was the most frequently used (7 studies) followed by Bayesian causal forest (4 studies). Most applications were in cardiology (6 studies), followed by psychiatry (4 studies). We provide example R codes to illustrate how to implement these algorithms. This review identified and outlined various algorithms currently used to identify HTEs and individualized treatment effects in RCT data. Given the increasing availability of new algorithms, analysts should carefully select them after examining model performance and considering how the models will be used in practice.

Sections du résumé

BACKGROUND BACKGROUND
Estimating heterogeneous treatment effects (HTEs) in randomized controlled trials (RCTs) has received substantial attention recently. This has led to the development of several statistical and machine learning (ML) algorithms to assess HTEs through identifying individualized treatment effects. However, a comprehensive review of these algorithms is lacking. We thus aimed to catalog and outline currently available statistical and ML methods for identifying HTEs via effect modeling using clinical RCT data and summarize how they have been applied in practice.
STUDY DESIGN AND SETTING METHODS
We performed a scoping review using pre-specified search terms in MEDLINE and Embase, aiming to identify studies that assessed HTEs using advanced statistical and ML methods in RCT data published from 2010 to 2022.
RESULTS RESULTS
Among a total of 32 studies identified in the review, 17 studies applied existing algorithms to RCT data, and 15 extended existing algorithms or proposed new algorithms. Applied algorithms included penalized regression, causal forest, Bayesian causal forest, and other meta-learner frameworks. Of these methods, causal forest was the most frequently used (7 studies) followed by Bayesian causal forest (4 studies). Most applications were in cardiology (6 studies), followed by psychiatry (4 studies). We provide example R codes to illustrate how to implement these algorithms.
CONCLUSION CONCLUSIONS
This review identified and outlined various algorithms currently used to identify HTEs and individualized treatment effects in RCT data. Given the increasing availability of new algorithms, analysts should carefully select them after examining model performance and considering how the models will be used in practice.

Identifiants

pubmed: 39305940
pii: S0895-4356(24)00294-4
doi: 10.1016/j.jclinepi.2024.111538
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111538

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Kosuke Inoue (K)

Department of Social Epidemiology, Graduate School of Medicine, Kyoto University, Japan; Hakubi Center, Kyoto University, Japan. Electronic address: inoue.kosuke.2j@kyoto-u.ac.jp.

Motohiko Adomi (M)

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

Orestis Efthimiou (O)

Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland; Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.

Toshiaki Komura (T)

Department of Epidemiology, School of Public Health, Boston University, Boston, MA, USA.

Kenji Omae (K)

Department of Innovative Research and Education for Clinicians and Trainees, Fukushima Medical University Hospital, Fukushima, Japan; Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University, Fukushima, Japan.

Akira Onishi (A)

Department of Advanced Medicine for Rheumatic Diseases, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Yusuke Tsutsumi (Y)

Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan; Department of Emergency Medicine, National Hospital Organization Mito Medical Center, Ibaraki, Japan.

Tomoko Fujii (T)

Intensive Care Unit, Jikei University Hospital, Tokyo, Japan; Departments of Health Promotion and Human Behavior and of Clinical Epidemiology, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan.

Naoki Kondo (N)

Department of Social Epidemiology, Graduate School of Medicine, Kyoto University, Japan.

Toshi A Furukawa (TA)

Departments of Health Promotion and Human Behavior and of Clinical Epidemiology, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan.

Classifications MeSH